Lien-Khuong Pham Tran, M.D.

67% fewer Medicare Part D claims than the average pulmonary disease physician in 2024

471 Medicare Part D claims for 119 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 64% of claims.

Most prescribed

1. Trelegy Ellipta75 claims
2. Albuterol Sulfate Hfa50 claims
3. Prednisone26 claims
4. Breztri Aerosphere20 claims
5. Montelukast Sodium20 claims
6. Pantoprazole Sodium18 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 73 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $179.32

9 payments; by number, the most common kind was food and beverage; the largest payer was United Therapeutics Corporation. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. EL-Bershawi Medical CorpRiverside, CA
2. Western Institute OF Critical Care Medicine, IncCorona, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).